| Nadah Bano Zafar, MD | |
|
10 Orms St, Suite 105, Providence, RI 02904-2228 | |
| (401) 444-5120 | |
| (401) 444-4307 |
| Full Name | Nadah Bano Zafar |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 35 Years |
| Location | 10 Orms St, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205842341 | NPI | - | NPPES |
| 7050066 | Medicaid | RI | |
| P01047398 | Other | TX | MEDICARE RAILROAD |
| 60451033 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD11224 (Rhode Island) | Secondary |
| 207P00000X | Emergency Medicine | N1500 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Las Palmas Medical Center | El paso, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Services Of Texas Pa | 7517289291 | 45 |
News Archive
Array BioPharma Inc. today announced presentations on encorafenib, binimetinib and selumetinib (licensed to AstraZeneca) at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 29 – June 2, 2015 in Chicago, Illinois.
For every person living with and affected by MS there is a unique story about how they move forward with their lives. That is why the National Multiple Sclerosis Society is launching We Keep Moving, a viewer-driven reality campaign that will capture these stories and perspectives through online videos that chronicle how people across the country keep moving forward while living with MS
More than half of all countries worldwide are struggling to prevent cancer and provide treatment and chronic care to cancer patients, warns a recent World Health Organization (WHO) survey for World Cancer Day. This means, currently many of these countries do not have a functional cancer control plan that includes prevention, early detection, treatment and care. There is an urgent need to help countries to reduce cancer deaths and provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development.
Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich®, today announced an extension to its award-winning CompoZr® product offering with the global release of the CompoZr Targeted Integration Kit, AAVS1. This kit provides a powerful method for the controlled transgene integration and expression of any gene in any human cell line using Sigma-Aldrich's proprietary CompoZr Zinc Finger Nuclease (ZFN) technology.
A research team at The Dartmouth Institute for Health Policy and Clinical Practice has received a $2 million funding award from the Patient-Centered Outcomes Research Institute to conduct a research project that is likely to change the way women and their doctors make decisions about breast cancer surgery.
› Verified 6 days ago
| Entity Name | Questcare Medical Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164574489 PECOS PAC ID: 6204739402 Enrollment ID: O20040127000697 |
News Archive
Array BioPharma Inc. today announced presentations on encorafenib, binimetinib and selumetinib (licensed to AstraZeneca) at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 29 – June 2, 2015 in Chicago, Illinois.
For every person living with and affected by MS there is a unique story about how they move forward with their lives. That is why the National Multiple Sclerosis Society is launching We Keep Moving, a viewer-driven reality campaign that will capture these stories and perspectives through online videos that chronicle how people across the country keep moving forward while living with MS
More than half of all countries worldwide are struggling to prevent cancer and provide treatment and chronic care to cancer patients, warns a recent World Health Organization (WHO) survey for World Cancer Day. This means, currently many of these countries do not have a functional cancer control plan that includes prevention, early detection, treatment and care. There is an urgent need to help countries to reduce cancer deaths and provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development.
Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich®, today announced an extension to its award-winning CompoZr® product offering with the global release of the CompoZr Targeted Integration Kit, AAVS1. This kit provides a powerful method for the controlled transgene integration and expression of any gene in any human cell line using Sigma-Aldrich's proprietary CompoZr Zinc Finger Nuclease (ZFN) technology.
A research team at The Dartmouth Institute for Health Policy and Clinical Practice has received a $2 million funding award from the Patient-Centered Outcomes Research Institute to conduct a research project that is likely to change the way women and their doctors make decisions about breast cancer surgery.
› Verified 6 days ago
| Entity Name | Emergency Services Of Texas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174932131 PECOS PAC ID: 7517289291 Enrollment ID: O20141208002099 |
News Archive
Array BioPharma Inc. today announced presentations on encorafenib, binimetinib and selumetinib (licensed to AstraZeneca) at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 29 – June 2, 2015 in Chicago, Illinois.
For every person living with and affected by MS there is a unique story about how they move forward with their lives. That is why the National Multiple Sclerosis Society is launching We Keep Moving, a viewer-driven reality campaign that will capture these stories and perspectives through online videos that chronicle how people across the country keep moving forward while living with MS
More than half of all countries worldwide are struggling to prevent cancer and provide treatment and chronic care to cancer patients, warns a recent World Health Organization (WHO) survey for World Cancer Day. This means, currently many of these countries do not have a functional cancer control plan that includes prevention, early detection, treatment and care. There is an urgent need to help countries to reduce cancer deaths and provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development.
Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich®, today announced an extension to its award-winning CompoZr® product offering with the global release of the CompoZr Targeted Integration Kit, AAVS1. This kit provides a powerful method for the controlled transgene integration and expression of any gene in any human cell line using Sigma-Aldrich's proprietary CompoZr Zinc Finger Nuclease (ZFN) technology.
A research team at The Dartmouth Institute for Health Policy and Clinical Practice has received a $2 million funding award from the Patient-Centered Outcomes Research Institute to conduct a research project that is likely to change the way women and their doctors make decisions about breast cancer surgery.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nadah Bano Zafar, MD 593 Eddy St, Providence, RI 02903-4923 Ph: (401) 444-5120 | Nadah Bano Zafar, MD 10 Orms St, Suite 105, Providence, RI 02904-2228 Ph: (401) 444-5120 |
News Archive
Array BioPharma Inc. today announced presentations on encorafenib, binimetinib and selumetinib (licensed to AstraZeneca) at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 29 – June 2, 2015 in Chicago, Illinois.
For every person living with and affected by MS there is a unique story about how they move forward with their lives. That is why the National Multiple Sclerosis Society is launching We Keep Moving, a viewer-driven reality campaign that will capture these stories and perspectives through online videos that chronicle how people across the country keep moving forward while living with MS
More than half of all countries worldwide are struggling to prevent cancer and provide treatment and chronic care to cancer patients, warns a recent World Health Organization (WHO) survey for World Cancer Day. This means, currently many of these countries do not have a functional cancer control plan that includes prevention, early detection, treatment and care. There is an urgent need to help countries to reduce cancer deaths and provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development.
Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich®, today announced an extension to its award-winning CompoZr® product offering with the global release of the CompoZr Targeted Integration Kit, AAVS1. This kit provides a powerful method for the controlled transgene integration and expression of any gene in any human cell line using Sigma-Aldrich's proprietary CompoZr Zinc Finger Nuclease (ZFN) technology.
A research team at The Dartmouth Institute for Health Policy and Clinical Practice has received a $2 million funding award from the Patient-Centered Outcomes Research Institute to conduct a research project that is likely to change the way women and their doctors make decisions about breast cancer surgery.
› Verified 6 days ago
Dr. Robert A Partridge, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Claverick 2, Providence, RI 02903 Phone: 401-519-1604 Fax: 401-272-0538 | |
Dr. Gregory R Lockhart, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Claverick 2, Providence, RI 02903 Phone: 401-444-4000 Fax: 401-427-7795 | |
Ian M Jacobson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 825 Chalkstone Ave, Providence, RI 02908 Phone: 330-493-4443 | |
Dr. Daniel Shanin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St., Claverick 2, Providence, RI 02903 Phone: 401-444-4000 | |
Carli Renske Reisdorf, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-6680 | |
Dr. Oriane Diana Longerstaey, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 164 Summit Ave, Providence, RI 02906 Phone: 704-355-3181 | |
Rachel Smith Shain, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-6489 Fax: 401-444-6662 |